MOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE

Similar documents
Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure

Advances in Melanoma

Rare melanoma: Are the options improving? Dr Neil Steven Consultant in Medical Oncology University Hospital Birmingham University of Birmingham

Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe

Breakthrough and Landscape of Acral and Mucosal Melanomas. Jun Guo. M.D., Ph.D Peking University Cancer Hospital & Institute

Racial differences in six major subtypes of melanoma: descriptive epidemiology

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

ORIGINAL ARTICLE Cutaneous malignant melanoma: clinical and histopathological review of cases in a Malaysian tertiary referral centre

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Prediction of Lymph Node Involvement in Patients with Breast Tumors Measuring 3 5 cm in a Middle-Income Setting: the Role of CancerMath

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

Impact of Prognostic Factors

Professor Michael Eccles

Epidemiology. Objectives 8/28/2017

Metastatic Melanoma. Cynthia Kwong February 16, 2017 SUNY Downstate Medical Center Department of Surgery Grand Rounds

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

Ethnic disparities in melanoma diagnosis and survival

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

What Pathology can tell us in the approach of localized colorectal cancer

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas

Prevalence of BRAF and NRAS Mutations and a Comparative Analysis in Primary and Metastatic Melanoma of Korean Patients

Contrast with Australian Guidelines A/Pr Pascale Guitera,

Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients

Rising incidence of breast cancer in Brunei Darussalam

Enrollment Form: Pancreas

Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Acral Melanoma in Japan

Your Future In Asia: Developing a market and protecting its health

Although melanoma affects individuals from all ethnic

Living Beyond Cancer Skin Cancer Detection and Prevention

Normal RAS-RAF (MAPK) pathway signaling

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

MALIGNANT MELANOMA OF THE HEEL

MALIGNANT MELANOMA AND OTHER MALIGNANCIES OF THE NASAL CAVITY AND THE PARANASAL SINUSES IN SWEDEN

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Index. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035

Protocol applies to melanoma of cutaneous surfaces only.

Melanoma Among Blacks in the United States MaryBeth Freeman, MPH ORISE Fellow

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D.

Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country

SUBUNGUAL MALIGNANT MELANOMA ON THE RIGHT INDEX IN A DENTIST AFTER PROLONGED OCCUPATIONAL EXPOSURE TO X-RAYS

Molecular and Cellular Tumor Pathology Laboratory, Cancer Center Karolinska,

Characteristics and Treatment of Cutaneous Melanoma of the Foot

Bersagli molecolari nel melanoma

Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure

KIT Inhibition in Advanced Melanoma: Rationale and Clinical i l Results

The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients

Interesting Case Series. Desmoplastic Melanoma

Melanoma Quality Reporting

Prof. Dr. Kutikuppala Surya Rao MD.,PhD.,MNAMS.,FHM(CMC Vellore) DFM.,FCGP.,FRCP(London)

Melanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

Clinical Pathological Conference. Malignant Melanoma of the Vulva

MELANOCYTIC LESIONS: EFFECTIVE MANAGEMENT IN PRIMARY CARE: Part 2

Pathology of the Thyroid

CAP Laboratory Improvement Programs. Worldwide Frequency of Commonly Detected EGFR Mutations

Dr Rosalie Stephens. Mr Richard Martin. Medical Oncologist Auckland City Hospital Auckland

Lung Cancer Genetics: Common Mutations and How to Treat Them David J. Kwiatkowski, MD, PhD. Mount Carrigain 2/4/17

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

Current and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian

Case Report Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation

Clinical Case Conference Melanoma

Horizon Scanning in Oncology

Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Recruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown

Clinicopathologic Self- Assessment S003 AAD 2017

Melanocytic Tumours. Molecular Biology 02/06/2015. Cutaneous Melanocytic Tumours Introduction. Thomas Brenn. Intermediate Malignancy

Dr. Brent Doolan, BSc MBBS MPH

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

STUDY. Incidence and Survival Patterns in the United States,

Microscopically diagnosed head and neck cancers in the University Hospital, Kuala Lumpur

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

SUPPLEMENTARY APPENDIX

Demographics. 2. What was your sex at birth? If female, participant is ineligible. End of form.

Epithelial Cancer- NMSC & Melanoma

cmet-n375s germline mutation is associated with poor prognosis of melanoma in Chinese patients

21/07/2017. The «gray zone» of diagnosis is visible. Nevus Atypical nevus Melanoma. Melanoma ex-blue nevus

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

ABSTRACT INTRODUCTION

MAPK Pathway. CGH Next Generation Sequencing. Molecular Tools in Care of Patients with Pigmented Lesions 7/20/2017

JPRAS Open 6 (2015) 59e66. Contents lists available at ScienceDirect. JPRAS Open. journal homepage:

Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience

Case Report A Rare Form of Melanoma Masquerading as adiabeticfootulcer:acasereport

DISCOVERY AND VALIDATION OF PROGNOSTIC MARKERS FOR CUTANEOUS MELANOMA

National University Hospital, Singapore.

Melanoma. Walt Mudie - Block 5

This online (electronic) survey contains twenty four simple questions. Those marked with an asterisk (*) must be answered.

Mesenchymal neoplasms of the gastrointestinal tract what s new? Newton ACS Wong Department of Histopathology Bristol Royal Infirmary

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

- Selected Tumors of the Skin Appendages - Primary vs. Metastasis

Malignant Melanoma of The Skin - Still A Medical Conundrum?

California Medicaid Enrollment and Melanoma Stage at Diagnosis A Population-Based Study

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Meta-Analyses of Epigenetics Risk Factors for Cardiovascular Health: APOA5 Human Gene Variations Across Different Race-Ethnicity Groups

Transcription:

MOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE PoYin Tan Inny Busmanis Dept of Anatomical Pathology, Lynette Oon Head, Molecular Lab Singapore General Hospital

ETHNIC GROUPS IN SINGAPORE Others,.% Indian, 9.% Malay,.% Chinese, 7.% Source: Singapore Department of Statistics, 0

? What is the Distribution of the Different Subtypes of Melanoma in the Singapore Population % Cutaneous 0 Acral 0 Mucosal 77 9* High % acral and mucosal subtypes * 9 cases melanoma retrieved from SGH files over year period

? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 50 Caucasian 0 9 Malay Indian Others 9 Total 7

? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 (%) 50 Caucasian 0 9 Malay Indian Others 9 Total 7

? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 (9%) 50 Caucasian 0 9 Malay Indian Others 9 Total 7

? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 50 (5%) Caucasian 0 9 Malay Indian Others 9 Total 7

? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 (%) 50 Caucasian 0 9 Malay Indian Others 9 Total 7

? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 50 Caucasian 0 9 (%) Malay Indian Others 9 Total 7

Ethnic Groups Represented in the Molecular Analysis Cases (0 total) 7 Chinese (7.%) Caucasian 7 Malay Indian 5 Others Indonesian Philipino Vietnamese

? What were the Categories of Melanoma According to Ethnic Group in the Molecular Cases Chinese Caucasian Malay Indian Others Cutaneous Acral 5 0 Mucosal 5 Total 0 Ranking of different types of melanoma remains the same Chinese majority in each type remains similar ; 0% skin % acral 7% mucosal Within this molecular subset the small number of Caucasians also had other tumour categories, so incidence of skin melanoma less, at 7%

? What Subtypes of Melanoma are Represented in the 5 Molecular Acral Group Cases ALM Nodular 0 Desmoplastic Lymph node metastasis with no residual disease at original site 5 Of all Acral location tumours: 5 cases BRAF cases ckit

Molecular Results According to Histologic Subtypes of Acral Tumour Subtype BRAF ckit + + inconclusive ALM 0 5 Nodular 0 Desmoplastic No residual Total 5 Total

Molecular Results of Acral ALM and Nodular Subtypes Subtype BRAF ckit + + inconclusive ALM 0 5 Nodular 0 BRAF +ve cases: ALM V00E % (/) Each T>A ckit +ve cases: ALM % (5/5) Nodular 0% (/0) Each T>A? What is the Incidence of BRAF & ckit Mutations in the Exclusively Chinese Ethnic Group & ALL Acral Location Subtypes BRAF +ve ckit +ve 0% (/0) % (/) Exon x Exon x Exon 7 x

? How do the BRAF & ckit Mutational Rates in Chinese, Acral Location Compare with the Mutation Status in Chinese with Cutaneous Melanoma Cutaneous: Ethnic group BRAF ckit + + Inconclusive Chinese 9 Caucasian 5 Malay Others Of ALL cutaneous cases BRAF + ve rate 55% (/) IF Caucasians excluded, BRAF +ve rate 5% (/0) Only total cases underwent ckit analysis; NIL +ve; one inconclusive

? What Were the BRAF Results According to Histologic Subtypes of Cutaneous Melanoma Subtype Nodular BRAF + SSM 0 5 5 LM Desmoplastic No residual disease 7 Note: Ckit numbers too small for analysis

? So How do the Singapore Results Compare with Other Asian & Caucasian Populations As expected, a higher proportion of acral & mucosal subtypes compared with Western figures Overall incidence of ALM subtype >% BRAF +ve % ALM 5 % skin ckit +ve % ALM NIL skin Of the skin melanomas, BRAF +ve rate highest in nodular subtype ; 7 % (/) SSM ; 50 % (5/0)

Although there is marked difference in proportions of melanoma subtypes, molecular profiles do not appear to differ in the Singapore population, compared with Western data Other figures from Asia include BRAF +ve rate in ALM in Korea, 9. % Japan,. %.9 % palm/sole,.5 % subungual An outlier in local Asian figures is another report from Japan which cites a BRAF +ve rate in ALM of 5 %! (/0)? Technique related * laser capture microdissection & pyrosequencing

Thank you